$MYG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Mirati Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Mirati Therapeutics, Inc.. Get notifications about new insider transactions in Mirati Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 8.49 | 40,000 | 339,600 | 47,204 | |
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 166.73 | 1,023 | 170,566 | 112,714 | 113.7 K to 112.7 K (-0.90 %) |
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 166.07 | 20,823 | 3,457,986 | 113,737 | 134.6 K to 113.7 K (-15.47 %) |
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 164.91 | 13,338 | 2,199,499 | 134,560 | 147.9 K to 134.6 K (-9.02 %) |
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 164.07 | 4,816 | 790,182 | 147,898 | 152.7 K to 147.9 K (-3.15 %) |
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 8.49 | 40,000 | 339,600 | 152,714 | 112.7 K to 152.7 K (+35.49 %) |
Apr 06 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Option Exercise | M | 6.78 | 2,250 | 15,255 | 0 | ||
Apr 06 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 180.00 | 282 | 50,760 | 3,475 | 3.8 K to 3.5 K (-7.51 %) | |
Apr 06 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 176.70 | 1,968 | 347,747 | 3,757 | 5.7 K to 3.8 K (-34.38 %) | |
Apr 06 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Buy | M | 6.78 | 2,250 | 15,255 | 5,725 | 3.5 K to 5.7 K (+64.75 %) | |
Mar 30 2021 | MYG | Mirati Therapeutic ... | Sharp Shalini | Option Exercise | A | 164.98 | 3,523 | 581,225 | 3,523 | ||
Mar 30 2021 | MYG | Mirati Therapeutic ... | Sharp Shalini | Grant | A | 0.00 | 2,424 | 0 | 2,424 | 0 to 2.4 K | |
Mar 22 2021 | MYG | Mirati Therapeutic ... | Hickey Benjamin | EVP, Chief Commerci ... | Option Exercise | M | 114.33 | 2,369 | 270,848 | 30,116 | |
Mar 22 2021 | MYG | Mirati Therapeutic ... | Hickey Benjamin | EVP, Chief Commerci ... | Sell | S | 177.71 | 431 | 76,591 | 26,812 | 27.2 K to 26.8 K (-1.58 %) |
Mar 22 2021 | MYG | Mirati Therapeutic ... | Hickey Benjamin | EVP, Chief Commerci ... | Sell | S | 176.42 | 1,350 | 238,171 | 27,243 | 28.6 K to 27.2 K (-4.72 %) |
Mar 22 2021 | MYG | Mirati Therapeutic ... | Hickey Benjamin | EVP, Chief Commerci ... | Sell | S | 175.54 | 588 | 103,216 | 28,593 | 29.2 K to 28.6 K (-2.02 %) |
Mar 22 2021 | MYG | Mirati Therapeutic ... | Hickey Benjamin | EVP, Chief Commerci ... | Buy | M | 114.33 | 2,369 | 270,848 | 29,181 | 26.8 K to 29.2 K (+8.84 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 410 | 0 | 3,578,040 | |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 11,971 | 12 | 3,578,450 | |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 195.90 | 1 | 196 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 410 | 0 | 3,135,967 | 3.1 M to 3.1 M (+0.01 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 198.00 | 200 | 39,600 | 3,135,557 | 3.1 M to 3.1 M (-0.01 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 196.12 | 20 | 3,922 | 3,135,757 | 3.1 M to 3.1 M (0.00 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 195.52 | 189 | 36,953 | 3,135,777 | 3.1 M to 3.1 M (-0.01 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 191.00 | 1 | 191 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 11,971 | 12 | 3,135,967 | 3.1 M to 3.1 M (+0.38 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 199.08 | 2,237 | 445,342 | 3,123,996 | 3.1 M to 3.1 M (-0.07 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 197.81 | 3,993 | 789,855 | 3,126,233 | 3.1 M to 3.1 M (-0.13 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 197.30 | 4,633 | 914,091 | 3,130,226 | 3.1 M to 3.1 M (-0.15 %) |
Mar 10 2021 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 195.82 | 1,107 | 216,773 | 3,134,859 | 3.1 M to 3.1 M (-0.04 %) |
Mar 09 2021 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 468,639 | 469 | 332,809 | |
Mar 09 2021 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 128,805 | 129 | 0 | |
Mar 09 2021 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 13,996 | 14 | 0 | |
Mar 09 2021 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 181.15 | 363,000 | 65,757,450 | 2,000,000 | 2.4 M to 2 M (-15.36 %) |
Mar 09 2021 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 181.00 | 4 | 724 | 2,363,000 | 2.4 M to 2.4 M (0.00 %) |
Mar 09 2021 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | M | 0.00 | 597,444 | 597 | 2,363,004 | 1.8 M to 2.4 M (+33.84 %) |
Mar 09 2021 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 181.15 | 37,000 | 6,702,550 | 230,333 | 267.3 K to 230.3 K (-13.84 %) |
Mar 09 2021 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 181.00 | 1 | 181 | 267,333 | 267.3 K to 267.3 K (0.00 %) |
Mar 09 2021 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | M | 0.00 | 13,996 | 14 | 267,334 | 253.3 K to 267.3 K (+5.52 %) |
Mar 04 2021 | MYG | Mirati Therapeutic ... | Cherrington Julie M | Sell | S | 203.00 | 10 | 2,030 | 1,475 | 1.5 K to 1.5 K (-0.67 %) | |
Mar 04 2021 | MYG | Mirati Therapeutic ... | Cherrington Julie M | Sell | S | 201.00 | 1,990 | 399,990 | 1,485 | 3.5 K to 1.5 K (-57.27 %) | |
Feb 03 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Option Exercise | M | 114.33 | 1,340 | 153,202 | 63,630 | |
Feb 03 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Sell | S | 194.38 | 1,340 | 260,469 | 30,638 | 32 K to 30.6 K (-4.19 %) |
Feb 03 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Buy | M | 114.33 | 1,340 | 153,202 | 31,978 | 30.6 K to 32 K (+4.37 %) |
Feb 03 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Option Exercise | M | 6.78 | 2,250 | 15,255 | 2,250 | ||
Feb 03 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 194.38 | 218 | 42,375 | 3,475 | 3.7 K to 3.5 K (-5.90 %) | |
Feb 03 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 192.32 | 300 | 57,695 | 3,693 | 4 K to 3.7 K (-7.51 %) | |
Feb 03 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 190.50 | 1,732 | 329,948 | 3,993 | 5.7 K to 4 K (-30.25 %) | |
Feb 03 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Buy | M | 6.78 | 2,250 | 15,255 | 5,725 | 3.5 K to 5.7 K (+64.75 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Option Exercise | M | 39.76 | 7,500 | 298,200 | 17,500 | ||
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 207.83 | 200 | 41,565 | 3,475 | 3.7 K to 3.5 K (-5.44 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 206.63 | 1,100 | 227,297 | 3,675 | 4.8 K to 3.7 K (-23.04 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 205.26 | 975 | 200,125 | 4,775 | 5.8 K to 4.8 K (-16.96 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 204.43 | 1,205 | 246,333 | 5,750 | 7 K to 5.8 K (-17.33 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 203.43 | 1,579 | 321,219 | 6,955 | 8.5 K to 7 K (-18.50 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 201.99 | 960 | 193,911 | 8,534 | 9.5 K to 8.5 K (-10.11 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 200.90 | 462 | 92,818 | 9,494 | 10 K to 9.5 K (-4.64 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 200.06 | 719 | 143,839 | 9,956 | 10.7 K to 10 K (-6.74 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 198.48 | 250 | 49,621 | 10,675 | 10.9 K to 10.7 K (-2.29 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Option Exercise | M | 39.76 | 7,500 | 298,200 | 17,500 | ||
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 197.14 | 50 | 9,857 | 10,925 | 11 K to 10.9 K (-0.46 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 207.83 | 200 | 41,565 | 3,475 | 3.7 K to 3.5 K (-5.44 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Buy | M | 39.76 | 7,500 | 298,200 | 10,975 | 3.5 K to 11 K (+215.83 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 206.63 | 1,100 | 227,297 | 3,675 | 4.8 K to 3.7 K (-23.04 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 205.26 | 975 | 200,125 | 4,775 | 5.8 K to 4.8 K (-16.96 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 204.43 | 1,205 | 246,333 | 5,750 | 7 K to 5.8 K (-17.33 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 203.43 | 1,579 | 321,219 | 6,955 | 8.5 K to 7 K (-18.50 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 201.99 | 960 | 193,911 | 8,534 | 9.5 K to 8.5 K (-10.11 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 200.90 | 462 | 92,818 | 9,494 | 10 K to 9.5 K (-4.64 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 200.06 | 719 | 143,839 | 9,956 | 10.7 K to 10 K (-6.74 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 198.48 | 250 | 49,621 | 10,675 | 10.9 K to 10.7 K (-2.29 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Sell | S | 197.14 | 50 | 9,857 | 10,925 | 11 K to 10.9 K (-0.46 %) | |
Feb 01 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Buy | M | 39.76 | 7,500 | 298,200 | 10,975 | 3.5 K to 11 K (+215.83 %) | |
Jan 28 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 5.40 | 2,292 | 12,377 | 100,273 | |
Jan 28 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 5.40 | 2,292 | 12,377 | 112,714 | 110.4 K to 112.7 K (+2.08 %) |
Jan 25 2021 | MYG | Mirati Therapeutic ... | Johnson Craig A | Option Exercise | M | 20.54 | 15,000 | 308,100 | 0 | ||
Jan 25 2021 | MYG | Mirati Therapeutic ... | Johnson Craig A | Sell | S | 214.75 | 334 | 71,728 | 3,475 | 3.8 K to 3.5 K (-8.77 %) | |
Jan 25 2021 | MYG | Mirati Therapeutic ... | Johnson Craig A | Sell | S | 213.62 | 44 | 9,399 | 3,809 | 3.9 K to 3.8 K (-1.14 %) | |
Jan 25 2021 | MYG | Mirati Therapeutic ... | Johnson Craig A | Sell | S | 212.98 | 3,372 | 718,151 | 3,853 | 7.2 K to 3.9 K (-46.67 %) | |
Jan 25 2021 | MYG | Mirati Therapeutic ... | Johnson Craig A | Sell | S | 211.94 | 4,562 | 966,852 | 7,225 | 11.8 K to 7.2 K (-38.70 %) | |
Jan 25 2021 | MYG | Mirati Therapeutic ... | Johnson Craig A | Sell | S | 210.81 | 3,183 | 671,004 | 11,787 | 15 K to 11.8 K (-21.26 %) | |
Jan 25 2021 | MYG | Mirati Therapeutic ... | Johnson Craig A | Sell | S | 210.01 | 3,505 | 736,070 | 14,970 | 18.5 K to 15 K (-18.97 %) | |
Jan 25 2021 | MYG | Mirati Therapeutic ... | Johnson Craig A | Buy | M | 20.54 | 15,000 | 308,100 | 18,475 | 3.5 K to 18.5 K (+431.65 %) | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | REED VICKIE S | SVP, Chief Account ... | Option Exercise | A | 214.47 | 6,499 | 1,393,841 | 6,499 | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | REED VICKIE S | SVP, Chief Account ... | Grant | A | 0.00 | 4,157 | 0 | 11,628 | 7.5 K to 11.6 K (+55.64 %) |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Hickey Benjamin | EVP, Chief Commerci ... | Option Exercise | A | 214.47 | 10,979 | 2,354,666 | 10,979 | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Hickey Benjamin | EVP, Chief Commerci ... | Grant | A | 0.00 | 7,023 | 0 | 26,812 | 19.8 K to 26.8 K (+35.49 %) |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Christensen Jamie | EVP, Chief Scientif ... | Option Exercise | A | 214.47 | 10,979 | 2,354,666 | 10,979 | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Christensen Jamie | EVP, Chief Scientif ... | Grant | A | 0.00 | 7,023 | 0 | 54,285 | 47.3 K to 54.3 K (+14.86 %) |
Jan 20 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 27.00 | 3,245 | 87,615 | 181,755 | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 214.47 | 30,742 | 6,593,237 | 30,742 | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 27.00 | 3,245 | 87,615 | 110,422 | 107.2 K to 110.4 K (+3.03 %) |
Jan 20 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Grant | A | 0.00 | 19,665 | 0 | 107,177 | 87.5 K to 107.2 K (+22.47 %) |
Jan 20 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Option Exercise | A | 214.47 | 2,155 | 462,183 | 2,155 | ||
Jan 20 2021 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Grant | A | 0.00 | 1,475 | 0 | 3,475 | 2 K to 3.5 K (+73.75 %) | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Option Exercise | A | 214.47 | 2,155 | 462,183 | 2,155 | ||
Jan 20 2021 | MYG | Mirati Therapeutic ... | Martinez Maria E | Grant | A | 0.00 | 1,475 | 0 | 3,475 | 2 K to 3.5 K (+73.75 %) | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Option Exercise | A | 214.47 | 2,155 | 462,183 | 2,155 | ||
Jan 20 2021 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Grant | A | 0.00 | 1,475 | 0 | 3,475 | 2 K to 3.5 K (+73.75 %) | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | A | 214.47 | 2,155 | 462,183 | 2,155 | ||
Jan 20 2021 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Grant | A | 0.00 | 1,475 | 0 | 5,731 | 4.3 K to 5.7 K (+34.66 %) | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Johnson Craig A | Option Exercise | A | 214.47 | 2,155 | 462,183 | 2,155 | ||
Jan 20 2021 | MYG | Mirati Therapeutic ... | Johnson Craig A | Grant | A | 0.00 | 1,475 | 0 | 3,475 | 2 K to 3.5 K (+73.75 %) | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Cherrington Julie M | Option Exercise | A | 214.47 | 2,155 | 462,183 | 2,155 | ||
Jan 20 2021 | MYG | Mirati Therapeutic ... | Cherrington Julie M | Grant | A | 0.00 | 1,475 | 0 | 3,475 | 2 K to 3.5 K (+73.75 %) | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Option Exercise | A | 214.47 | 2,155 | 462,183 | 2,155 | ||
Jan 20 2021 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Grant | A | 0.00 | 1,475 | 0 | 40,527 | 39.1 K to 40.5 K (+3.78 %) | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Hasnain Faheem | Option Exercise | A | 214.47 | 3,064 | 657,136 | 3,064 | ||
Jan 20 2021 | MYG | Mirati Therapeutic ... | Hasnain Faheem | Grant | A | 0.00 | 2,098 | 0 | 5,098 | 3 K to 5.1 K (+69.93 %) | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Option Exercise | A | 214.47 | 10,979 | 2,354,666 | 10,979 | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Grant | A | 0.00 | 7,023 | 0 | 30,638 | 23.6 K to 30.6 K (+29.74 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | REED VICKIE S | SVP, Chief Account ... | Sell | S | 216.33 | 241 | 52,135 | 7,471 | 7.7 K to 7.5 K (-3.12 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | REED VICKIE S | SVP, Chief Account ... | Sell | S | 210.28 | 527 | 110,818 | 7,712 | 8.2 K to 7.7 K (-6.40 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | REED VICKIE S | SVP, Chief Account ... | Sell | S | 215.70 | 11 | 2,373 | 8,239 | 8.3 K to 8.2 K (-0.13 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | Hickey Benjamin | EVP, Chief Commerci ... | Sell | S | 216.33 | 2,069 | 447,587 | 19,789 | 21.9 K to 19.8 K (-9.47 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | Hickey Benjamin | EVP, Chief Commerci ... | Sell | S | 215.31 | 9 | 1,938 | 21,858 | 21.9 K to 21.9 K (-0.04 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | Christensen Jamie | EVP, Chief Scientif ... | Sell | S | 210.28 | 1,430 | 300,700 | 47,262 | 48.7 K to 47.3 K (-2.94 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | Christensen Jamie | EVP, Chief Scientif ... | Sell | S | 215.87 | 29 | 6,260 | 48,692 | 48.7 K to 48.7 K (-0.06 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Sell | S | 216.33 | 2,613 | 565,270 | 23,615 | 26.2 K to 23.6 K (-9.96 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Sell | S | 215.31 | 12 | 2,584 | 26,228 | 26.2 K to 26.2 K (-0.05 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 210.28 | 4,421 | 929,648 | 87,512 | 91.9 K to 87.5 K (-4.81 %) |
Jan 08 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 215.76 | 90 | 19,418 | 91,933 | 92 K to 91.9 K (-0.10 %) |
Dec 31 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Gift | G | 0.00 | 10,000 | 0 | 92,023 | 102 K to 92 K (-9.80 %) |
Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 8.49 | 40,000 | 339,600 | 87,204 | |
Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 240.23 | 317 | 76,153 | 102,023 | 102.3 K to 102 K (-0.31 %) |
Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 238.76 | 100 | 23,876 | 102,340 | 102.4 K to 102.3 K (-0.10 %) |
Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 237.26 | 2,020 | 479,255 | 102,440 | 104.5 K to 102.4 K (-1.93 %) |
Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 236.17 | 4,250 | 1,003,732 | 104,460 | 108.7 K to 104.5 K (-3.91 %) |
Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 235.20 | 493 | 115,956 | 108,710 | 109.2 K to 108.7 K (-0.45 %) |
Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 234.26 | 22,932 | 5,371,998 | 109,203 | 132.1 K to 109.2 K (-17.35 %) |
Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 233.43 | 9,888 | 2,308,145 | 132,135 | 142 K to 132.1 K (-6.96 %) |
Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 8.49 | 40,000 | 339,600 | 142,023 | 102 K to 142 K (+39.21 %) |
Dec 16 2020 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Option Exercise | M | 20.54 | 10,000 | 205,400 | 6,000 | ||
Dec 16 2020 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Sell | S | 237.90 | 40 | 9,516 | 2,000 | 2 K to 2 K (-1.96 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Sell | S | 237.36 | 451 | 107,049 | 2,040 | 2.5 K to 2 K (-18.11 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Sell | S | 235.19 | 1,821 | 428,284 | 2,491 | 4.3 K to 2.5 K (-42.23 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Sell | S | 234.27 | 610 | 142,907 | 4,312 | 4.9 K to 4.3 K (-12.39 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Sell | S | 233.40 | 4,461 | 1,041,207 | 4,922 | 9.4 K to 4.9 K (-47.54 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Sell | S | 232.01 | 1,399 | 324,576 | 9,383 | 10.8 K to 9.4 K (-12.98 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Sell | S | 230.19 | 1,218 | 280,368 | 10,782 | 12 K to 10.8 K (-10.15 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Buy | M | 20.54 | 10,000 | 205,400 | 12,000 | 2 K to 12 K (+500.00 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Option Exercise | M | 6.78 | 2,250 | 15,255 | 4,500 | ||
Dec 16 2020 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 248.96 | 1 | 249 | 2,000 | 2 K to 2 K (-0.05 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 248.28 | 357 | 88,634 | 2,001 | 2.4 K to 2 K (-15.14 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 247.63 | 710 | 175,817 | 2,358 | 3.1 K to 2.4 K (-23.14 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 246.27 | 257 | 63,292 | 3,068 | 3.3 K to 3.1 K (-7.73 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 244.97 | 589 | 144,287 | 3,325 | 3.9 K to 3.3 K (-15.05 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 244.05 | 287 | 70,041 | 3,914 | 4.2 K to 3.9 K (-6.83 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Sell | S | 240.93 | 49 | 11,806 | 4,201 | 4.3 K to 4.2 K (-1.15 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Buy | M | 6.78 | 2,250 | 15,255 | 4,250 | 2 K to 4.3 K (+112.50 %) |